Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma.

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/42087

Title:	Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma.
Authors:	Tseng, JS Yang, TY Chen, KC Hsu, KH Yu, CJ Liao, WY Tsai, CR Tsai, MH Yu, SL Su, KY Chen, JJ Chen, HY Chang, GC
Issue Date:	2014
Relation:	OncoTargets and therapy 7, 799-805
URI:	http://ir.sinica.edu.tw/handle/201000000A/42087
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1178-6930&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://www.ncbi.nlm.nih.gov/pubmed/24920920?dopt=Citation
Appears in Collections:	統計科學研究所

Show full item record

Last Week
0

Last month

checked on May 9, 2025

Check